Senator Risa Hontiveros is urging the Department of Health (DOH) to rethink its policy of not disclosing COVID-19 vaccine brands before inoculation, citing potential negative impacts on public trust.
Hontiveros believes that such policies can foster public doubt regarding the national vaccination program.
She argued that the DOH is failing to adequately inform the public that all available COVID-19 vaccines are safe and effective, regardless of the brand.
The senator emphasized the importance of respecting patients by providing them with proper information to make an informed decision and give consent before vaccination.
Hontiveros also stated that transparency in vaccine information could help assure citizens and lead to more organized vaccination processes, potentially preventing overcrowding.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.




